Receptor-level evidence further supports these effects: overexpression of the SAA receptor Tanis in hepatocytes impairs insulin-stimulated glucose uptake and glycogen synthesis [73], while SELS expression in adipose tissue correlates positively with glycemic control in humans with T2DM [169]. This evidence concerns the gene INS and type 2 diabetes mellitus.